{"name":"Hangzhou Converd Co., Ltd.","slug":"hangzhou-converd-co-ltd","ticker":"","exchange":"","domain":"hangzhouconverd.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"anticancer medication A01; immune cells IC01","genericName":"anticancer medication A01; immune cells IC01","slug":"anticancer-medication-a01-immune-cells-ic01","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"anticancer medication A01; immune cells IC01","genericName":"anticancer medication A01; immune cells IC01","slug":"anticancer-medication-a01-immune-cells-ic01","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxNY3A2YmU5QTE4OEpCUG1XdmFQT1lpUC1ieVgzX3hIWi1yWUFPVTBxWURCdFljZzRWWk0tbk45VnBoUHp2SWVyZXFzMVhrX3NKS2liTkNtb0llZnlxdkdrSHBzWUhncVZvTFkwcnlPbHU5R0MwTV9WMmdEWDB3QVlXcGJhTzZuVkNQa2xKb0J6dU1FXy1QU1VGSmhZaDlYbWdpVUlGWm0ybkhQbjVWaUk3T1JGLURzZ2xKckN4UFJzRTBfbG1tYTlWekN5NkJZQ2ZNLVBGbEl1N0lBMDVMM1hldVlwTVhZRjNnbWZXT21DbzlTZGJfczdDTGctajZHeUFibUJ6NlBqX2t4M0hBWWliNUZISnlObTRBeGZZSHo2UDBUY2NuWkRWTFBQVndvVkxhOEE?oc=5","date":"2026-04-07","type":"pipeline","source":"Barchart.com","summary":"Oncolytic Virus Therapies Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | CG Oncology, Imugene, Amgen, Daiichi Sankyo, Genelux, Replimune, Binhui Biopharma - Barchart.com","headline":"Oncolytic Virus Therapies Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | CG Oncology, Imugene, Amge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOQTR0d1l3a3B2VmdFdjY0QkJVZ01rYmtPV0gtNERtMXMyN1lXdTdpOTFRRjFjREFaSENvbDByU2JUdzRVZ2Mxc3dsbU8zYm5MUElhVGl3RHkyU3NzaTZ5b3U2T1NOUGlUaE90MDNtUTB1Z2xIeWRSZ1NfTEpwU1hzcDZiZnpYX0puU1lTZmYyMDZ6YS02YnowdU1jbU1wZmh0d3pYNmpiYV9VVnpzTXRva09wdE9RUzZ1d3dWOGtVMGJwVmFaVkJndlJMM09oSWRhUWZKVUJJSW1iSXBWc0p5bm83ZlZOYmxaZXdEOG1ZZHZib2pxcUltWmFrdjJha0JhRFNKYTF3QlFjd0hEN29VTVJB?oc=5","date":"2026-02-04","type":"trial","source":"prnewswire.com","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - prnewswire.com","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOdE1PeEdGcDZYMURsU19waml2Q0pQT2JpT1dwRXRmdXBSS3JKNDc5eHpIQ1BLUVFIMU5WcDFxTXVsOXdUbl9ySko1MlRlZWJuM2NyMS1LSTY0cWRJVnZBX0dzQzk5OG1IcUJ4QkxEV2syNzNGYVQza0JDOFN2WURwb0NDUlAzeDlGa1NpYW13aFpnazJtWUVJRl9QZ0k5MUR1MVgzbnRWcUp1alNQd2l3ZFRB?oc=5","date":"2025-05-14","type":"pipeline","source":"BioWorld News","summary":"Integrating antibody therapy and oncolytic virotherapy enhances effects - BioWorld News","headline":"Integrating antibody therapy and oncolytic virotherapy enhances effects","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}